Search PubMedSearch

Biomedical subjects

Dan He

Publications and source records attributed to Dan He.

2 recordsLinked to original sources

Adolescent depression as a systemic multimorbidity catalyst: integrated genetic and metabolic pathway analysis.

BACKGROUND: Although adolescent depression has been linked to individual chronic conditions, its broader role in shaping multimorbidity risk remains understudied. METHODS: A total of 87,562 UK Biobank participants were included, of whom 18,851 had documented adolescent depression. Cox proportional hazards models were applied to evaluate associations between adolescent depression and 24 chronic diseases, followed by stratified analyses by sex and age. Two-sample Mendelian randomization (MR) was then conducted to infer causality for diseases showing significant associations. Genomic colocalization analyses were performed using relevant GWAS data to identify shared causal variants. Mediation analyses were performed to detect possible mediating factors, including the frailty index, KDM biological age acceleration, allostatic load and 30 circulating biomarkers. RESULTS: Adolescent depression was associated with elevated risk for 12 chronic diseases, with strongest associations for hypothyroidism (HR = 1.29 [1.18-1.42]), diabetes (HR = 1.25 [1.13-1.38]) and chronic obstructive pulmonary disease (COPD) (HR = 1.74 [1.50-2.01]). Risks were notably higher among females and younger adults. MR confirmed likely causal relationships for hypothyroidism (OR = 1.45 [1.03-2.05]), diabetes (OR = 1.01 [1.01-1.02]) and COPD (OR = 1.04 [1.02-1.06]). Genomic colocalization revealed a shared genetic signal at the CDSN/PSORS1C1 locus between adolescent depression and hypothyroidism. Mediation analyses revealed disease-specific pathways: creatinine for hypothyroidism, testosterone for diabetes, KDM biological ageing for COPD and frailty index across all three conditions. CONCLUSIONS: Adolescent depression confers systemic vulnerability through genetic and metabolic mechanisms, with amplified risks in females and individuals aged ≤55 years. These findings support early, integrated interventions to mitigate long-term multimorbidity.

Humans

Redox-activated chemistry for probing and perturbing the proteome: Lessons from protein redox switches.

Covalent drug discovery and chemical proteomics have historically relied on a nucleophilic logic, where electrophilic "warheads" react with nucleophilic amino acid side chains. While powerful, this paradigm probes only a single dimension of the protein's chemical surface. In contrast, biology leverages a second axis: redox potential. This is exemplified by the regulated redox proteome, where specific residues undergo reversible oxidation and reduction as functional post-translational modifications. Inspired by this natural machinery, researchers are developing redox-activated probes to label proteins at oxidizable residues and deploying similar chemistry to selectively perturb protein function. This review highlights recent advances in redox-activated covalent chemistry and explores its burgeoning potential for the development of next-generation targeted therapeutics.

Oxidation-Reduction